It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
Fact checked by Nick Blackmer The Biden Administration proposed a new rule that would require Medicare and Medicaid to cover ...
WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be ...
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...